J 2023

Lipoprotein Subfractions Associated with Endothelial Function in Previously Healthy Subjects with Newly Diagnosed Sleep Apnea-A Pilot Study

HLUCHANOVA, Alzbeta, Branislav KOLLAR, Katarina KLOBUCNIKOVA, Miroslava HARDONOVA, Michal PODDANY et. al.

Základní údaje

Originální název

Lipoprotein Subfractions Associated with Endothelial Function in Previously Healthy Subjects with Newly Diagnosed Sleep Apnea-A Pilot Study

Autoři

HLUCHANOVA, Alzbeta, Branislav KOLLAR, Katarina KLOBUCNIKOVA, Miroslava HARDONOVA, Michal PODDANY, Ingrid ZITNANOVA, Monika DVORAKOVA, Katarina KONARIKOVA, Miroslav TEDLA, Milan URÍK (703 Slovensko, domácí), Pavel KLAIL, Petr SKOPEK, Peter TURCANI a Pavel SIARNIK

Vydání

LIFE-BASEL, BASEL, MDPI, 2023, 2075-1729

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30206 Otorhinolaryngology

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.200 v roce 2022

Kód RIV

RIV/00216224:14110/23:00130663

Organizační jednotka

Lékařská fakulta

UT WoS

000941407900001

Klíčová slova anglicky

lipoprotein subfractions; obstructive sleep apnea; polysomnography

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 27. 4. 2023 12:30, Mgr. Tereza Miškechová

Anotace

V originále

Background: Obstructive sleep apnea (OSA) activates several pathophysiological mechanisms which can lead to the development of vascular diseases. Endothelial dysfunction (ED) is an initial step in the development of atherosclerosis. The association between ED and OSA has been described in several studies, even in previously healthy subjects. High-density lipoproteins (HDL) were generally considered to be atheroprotective, and low-density lipoprotein (LDL) to be an atherogenic component of lipoproteins. However, recent findings suggest a pro-atherogenic role of small HDL subfractions (8-10) and LDL subfractions (3-7). This study aimed to evaluate the relationship between endothelial function and lipid subfractions in previously healthy OSA subjects. Material and Methods: We prospectively enrolled 205 subjects with sleep monitoring. Plasma levels of triacylglycerols, total cholesterol, LDL, HDL, and their subfractions were assessed. Endothelial function was determined using peripheral arterial tonometry, and reperfusion hyperemia index (RHI) was assessed. Results: Plasma levels of small and intermediate HDL subfractions have statistically significant pro-atherogenic correlations with endothelial function (p = 0.015 and p = 0.019). In other lipoprotein levels, no other significant correlation was found with RHI. In stepwise multiple linear regression analysis, small HDL (beta = -0.507, p = 0.032) was the only significant contributor in the model predicting RHI. Conclusions: In our studied sample, a pro-atherogenic role of small HDL subfractions in previously healthy subjects with moderate-to-severe OSA was proven.